Tybourne Capital Management’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Buy |
786,647
+166,666
| +27% | +$2.15M | 29.45% | 1 |
|
|
2025
Q1 | $4.81M | Hold |
619,981
| – | – | 20.42% | 4 |
|
|
2024
Q4 | $14.1M | Buy |
619,981
+475,000
| +328% | +$10.8M | 3.53% | 11 |
|
|
2024
Q3 | $810K | Sell |
144,981
-1
| -0% | -$6 | 0.23% | 30 |
|
|
2024
Q2 | $1.95M | Hold |
144,982
| – | – | 0.4% | 24 |
|
|
2024
Q1 | $2.52M | Hold |
144,982
| – | – | 0.43% | 18 |
|
|
2023
Q4 | $2.98M | Hold |
144,982
| – | – | 0.44% | 21 |
|
|
2023
Q3 | $2.4M | Buy |
+144,982
| New | +$2.4M | 0.34% | 19 |
|